BACKGROUND: Acinetobacter baumannii (Ab) is emerging as a multidrug-resistant (MDR) nosocomial pathogen of considerable clinical importance. Data on the efficacy of infection control measures in endemic situations are lacking. Here, we investigated the impact of a long-term multifaceted "bundle" approach in controlling endemic MDR Ab in a 950-bed tertiary care center. METHODS: Ongoing staff education, promotion of hand hygiene, strict Contact and Isolation Precautions, environmental cleaning, and targeted active surveillance in high-risk areas during periods of likely transmission and contamination were initiated in this program. To assess the efficacy of our interventions, we recorded (before and after the intervention) the epidemiologic and clinical features of MDR Ab infections and determined the clonal relationship among MDR Ab bloodstream isolates by pulsed-field gel electrophoresis. RESULTS: Before the "bundle" was instituted, the rate of colonization/infection was 0.82 cases per 100 admissions (1994-1995). Colonization/infection rates showed a sustained decrease after implementation of the control program in 1995 to 0.46 in 1996-1997 and to 0.21 in 1998-2003 (P < .001). Coincident with the institution of this program, the rate of bacteremia because of MDR Ab decreased 6-fold during the 8-year observation period. A notable change in the clonal distribution of the MDR Ab isolates was also demonstrated. CONCLUSION: The implementation of a comprehensive and multifaceted infection control program ("bundle") in a tertiary care center effectively controlled the spread and clinical impact of MDR Ab.
BACKGROUND:Acinetobacter baumannii (Ab) is emerging as a multidrug-resistant (MDR) nosocomial pathogen of considerable clinical importance. Data on the efficacy of infection control measures in endemic situations are lacking. Here, we investigated the impact of a long-term multifaceted "bundle" approach in controlling endemic MDR Ab in a 950-bed tertiary care center. METHODS: Ongoing staff education, promotion of hand hygiene, strict Contact and Isolation Precautions, environmental cleaning, and targeted active surveillance in high-risk areas during periods of likely transmission and contamination were initiated in this program. To assess the efficacy of our interventions, we recorded (before and after the intervention) the epidemiologic and clinical features of MDR Ab infections and determined the clonal relationship among MDR Ab bloodstream isolates by pulsed-field gel electrophoresis. RESULTS: Before the "bundle" was instituted, the rate of colonization/infection was 0.82 cases per 100 admissions (1994-1995). Colonization/infection rates showed a sustained decrease after implementation of the control program in 1995 to 0.46 in 1996-1997 and to 0.21 in 1998-2003 (P < .001). Coincident with the institution of this program, the rate of bacteremia because of MDR Ab decreased 6-fold during the 8-year observation period. A notable change in the clonal distribution of the MDR Ab isolates was also demonstrated. CONCLUSION: The implementation of a comprehensive and multifaceted infection control program ("bundle") in a tertiary care center effectively controlled the spread and clinical impact of MDR Ab.
Authors: Anthony D Harris; Douglas D Bradham; Mona Baumgarten; Ilene H Zuckerman; Jeffrey C Fink; Eli N Perencevich Journal: Clin Infect Dis Date: 2004-05-12 Impact factor: 9.079
Authors: J L García-Garmendia; C Ortiz-Leyba; J Garnacho-Montero; F J Jiménez-Jiménez; J Monterrubio-Villar; M Gili-Miner Journal: Crit Care Med Date: 1999-09 Impact factor: 7.598
Authors: B Mulin; D Talon; J F Viel; C Vincent; R Leprat; M Thouverez; Y Michel-Briand Journal: Eur J Clin Microbiol Infect Dis Date: 1995-07 Impact factor: 3.267
Authors: David Landman; John M Quale; David Mayorga; Adedeyo Adedeji; Kalyani Vangala; Jayshree Ravishankar; Carlos Flores; Steven Brooks Journal: Arch Intern Med Date: 2002-07-08
Authors: Ji Hoon Baang; Peter Axelrod; Brooke K Decker; Andrea M Hujer; Georgia Dash; Allan R Truant; Robert A Bonomo; Thomas Fekete Journal: Am J Infect Control Date: 2011-08-11 Impact factor: 2.918
Authors: Amy Ray; Federico Perez; Amanda M Beltramini; Marta Jakubowycz; Patricia Dimick; Michael R Jacobs; Kathy Roman; Robert A Bonomo; Robert A Salata Journal: Infect Control Hosp Epidemiol Date: 2010-10-25 Impact factor: 3.254
Authors: Andrea Endimiani; Kristine M Hujer; Andrea M Hujer; Isabelle Bertschy; Alexandra Rossano; Christoph Koch; Vinzenz Gerber; Thierry Francey; Robert A Bonomo; Vincent Perreten Journal: J Antimicrob Chemother Date: 2011-07-06 Impact factor: 5.790
Authors: José Garnacho-Montero; George Dimopoulos; Garyphallia Poulakou; Murat Akova; José Miguel Cisneros; Jan De Waele; Nicola Petrosillo; Harald Seifert; Jean François Timsit; Jordi Vila; Jean-Ralph Zahar; Matteo Bassetti Journal: Intensive Care Med Date: 2015-10-05 Impact factor: 17.440
Authors: Natalia Blanco; Anthony D Harris; Clare Rock; J Kristie Johnson; Lisa Pineles; Robert A Bonomo; Arjun Srinivasan; Melinda M Pettigrew; Kerri A Thom Journal: Antimicrob Agents Chemother Date: 2017-12-21 Impact factor: 5.191